IDUA Antikörper
-
- Target Alle IDUA Antikörper anzeigen
- IDUA (Iduronidase, alpha-L- (IDUA))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IDUA Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of human IDUA
- Isotyp
- IgG
- Top Product
- Discover our top product IDUA Primärantikörper
-
anti-Iduronidase, alpha-L- (IDUA) (AA 236-264) antibody
IDUA Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB26860 unconjugated
anti-Iduronidase, alpha-L- (IDUA) (AA 28-306) antibodyIDUA Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Iduronidase, alpha-L- (IDUA) (AA 28-653) antibodyIDUA Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Iduronidase, alpha-L- (IDUA) antibodyIDUA Reaktivität: Human, Maus ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Iduronidase, alpha-L- (IDUA) (AA 101-200) antibodyIDUA Reaktivität: Ratte ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Iduronidase, alpha-L- (IDUA) (AA 121-170) antibodyIDUA Reaktivität: Human, Maus, Meerschweinchen, Pferd, Rind (Kuh), Hamster WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- IHC 1:30-1:150, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.96 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- IDUA (Iduronidase, alpha-L- (IDUA))
- Andere Bezeichnung
- IDUA (IDUA Produkte)
- Hintergrund
- This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I).
- UniProt
- P35475
- Pathways
- Glycosaminoglycan Metabolic Process
-
